tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Alterity Therapeutics Ltd (ADR) trading halted, news pending
PremiumThe FlyAlterity Therapeutics Ltd (ADR) trading halted, news pending
23d ago
Alterity Therapeutics reports cash balance of A$40.66M as of June 30
Premium
The Fly
Alterity Therapeutics reports cash balance of A$40.66M as of June 30
2M ago
Buy Rating for Alterity Therapeutics: Promising Phase 2 Results and Investment Opportunity Amid Stock Price Dip
Premium
Ratings
Buy Rating for Alterity Therapeutics: Promising Phase 2 Results and Investment Opportunity Amid Stock Price Dip
2M ago
Alterity Therapeutics has several presentations featured at 2025 MSA Congress
PremiumThe FlyAlterity Therapeutics has several presentations featured at 2025 MSA Congress
5M ago
Alterity Therapeutics has several presentations featured at 2025 MSA Congress
Premium
The Fly
Alterity Therapeutics has several presentations featured at 2025 MSA Congress
5M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
Alterity Therapeutics Announces Director Securities Changes
PremiumCompany AnnouncementsAlterity Therapeutics Announces Director Securities Changes
5M ago
Alterity presents ATH434-201 Phase 2 trial results at MSA Symposium
Premium
The Fly
Alterity presents ATH434-201 Phase 2 trial results at MSA Symposium
5M ago
Promising Phase 2 Results and Technological Integration Justify Buy Rating for Alterity Therapeutics
Premium
Ratings
Promising Phase 2 Results and Technological Integration Justify Buy Rating for Alterity Therapeutics
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100